内质网
化学免疫疗法
纳米医学
癌症研究
体内
合理设计
化学
免疫原性细胞死亡
细胞凋亡
免疫系统
骨肉瘤
程序性细胞死亡
细胞
细胞生物学
纳米技术
机制(生物学)
生物
免疫疗法
计算生物学
药物发现
生物医学
医学
作者
Delong Huang,Zisis Papadopoulos,Tang Dongsheng,Nicolás Montesdeoca,Meifang Shen,Hanchen Zhang,Minhui Cui,Johannes Karges,Yingjie Yu,Haihua Xiao,Ganghao Liang
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-11-16
标识
DOI:10.1021/acsnano.5c20201
摘要
Osteosarcoma is a highly aggressive bone tumor characterized by profound chemoresistance and immune evasion, resulting in poor clinical prognoses. The rational design of metallodrugs to overcome these obstacles is a formidable challenge, as traditional discovery methods are inefficient for predicting the organelle-specific targeting required for specific mechanisms of action. Here, we introduce a machine learning-driven platform to rationally design and identify endoplasmic reticulum (ER)-targeting Ga(III) complexes capable of activating nonapoptotic immunogenic cell death. This strategy identified Ga20, a complex that triggers a dual mechanism of paraptosis and immunogenic cell death (ICD), directly addressing osteosarcoma’s apoptosis resistance. Formulated as a polymeric nanoparticle (Ga NP) for targeted in vivo delivery, this nanomedicine demonstrated profound tumor growth inhibition across aggressive and clinically relevant orthotopic, metastatic, bilateral, and patient-derived xenograft models. Critically, Ga NP treatment generated a durable in situ vaccine effect, conferring long-term immune memory and preventing tumor recurrence and metastasis. This work establishes a strategy for the computational design of organelle-targeted metallodrugs and presents a powerful chemoimmunotherapy that directly addresses the core clinical challenges of osteosarcoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI